→Appendix 1: tolterodine
PDF page 845
▶Common or very common Abdominal pain. bronchitis.
chest pain. diarrhoea. dry eye. fatigue. gastrointestinal
disorders. paraesthesia. peripheral oedema. vertigo.
weight increased
▶Uncommon Arrhythmia. heart failure. memory loss.
nervousness
▶Frequency not known Hallucination
PDF page 845
Manufacturer advises avoid—toxicity in
animal studies.
PDF page 845
Manufacturer advises avoid—no
information available.
PDF page 845
Manufacturer advises caution (risk
of increased exposure).
Dose adjustments For immediate-release medicines,
manufacturer advises dose reduction to 1 mg twice daily.
For modified-release capsules, manufacturer advises dose
reduction to 2 mg once daily.
PDF page 845
Manufacturer advises caution (risk of
increased exposure)
Dose adjustments For immediate-release medicines,
manufacturer advises dose reduction to 1 mg twice daily if
GFR less than or equal to 30 mL/minute.
For modified-release capsules, manufacturer advises dose
reduction to 2 mg once daily if GFR less than or equal to
30 mL/minute.
PDF page 845